A Study to Evaluate the Efficacy and Safety of OsrHSA in Patients of Hepatic Cirrhosis With Hypoalbuminemia

NCT06355479 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

328

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypoalbuminemia
Hepatic Cirrhosis

Interventions

DRUG: OsrHSA
DRUG: Plasbumin®-20

Sponsor

Healthgen Biotechnology Corp.